In addition, we identified 252 novel rare deleterious variants in 17 known PAH risk genes and confirmed the importance of TBX4 and SOX17 in early-onset disease as well as the association of GDF2 with IPAH. This evidence concerns the gene TBX4 and idiopathic pulmonary arterial hypertension.